|
TLK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.737089999998E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.16850000001045E-06 |
| Normal-vs-Stage2 |
6.628000E-02 |
| Normal-vs-Stage3 |
3.236400E-01 |
| Normal-vs-Stage4 |
3.461000E-01 |
| Stage1-vs-Stage2 |
4.519000E-01 |
| Stage1-vs-Stage3 |
9.403500E-02 |
| Stage1-vs-Stage4 |
4.223400E-01 |
| Stage2-vs-Stage3 |
5.424000E-01 |
| Stage2-vs-Stage4 |
8.190200E-01 |
| Stage3-vs-Stage4 |
7.999600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.71400000046485E-07 |
| Normal-vs-AfricanAmerican |
1.469550E-01 |
| Normal-vs-Asian |
3.591600E-01 |
| Caucasian-vs-AfricanAmerican |
1.181630E-01 |
| Caucasian-vs-Asian |
7.551600E-01 |
| AfricanAmerican-vs-Asian |
7.782800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.31899999705954E-08 |
| Normal-vs-Female |
7.223000E-01 |
| Male-vs-Female |
3.150200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.844000E-03 |
| Normal-vs-Extreme_Weight |
1.08069997395432E-09 |
| Normal-vs-Obese |
6.752200E-02 |
| Normal-vs-Extreme_Obese |
8.338400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.285590E-01 |
| Normal_Weight-vs-Obese |
3.534400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.915000E-01 |
| Extreme_Weight-vs-Obese |
3.338900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.299800E-01 |
| Obese-vs-Extreme_Obese |
7.363200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.924800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.584900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.43189999968207E-07 |
| Normal-vs-Age(81-100Yrs) |
4.376500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.451700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.143450E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.283660E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.196330E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.290580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.186200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.58319999946188E-07 |
| Normal-VS-Type2 PRCC |
4.363500E-04 |
| Normal-VS-KIRP CIMP |
3.097400E-01 |
| Normal-VS-Unclassified PRCC |
4.044200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.443000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.849400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.057030E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.240900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.501180E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.912640E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.634700E-04 |
| Normal-vs-N1 |
4.813600E-01 |
| Normal-vs-N2 |
2.164100E-02 |
| N0-vs-N1 |
3.677400E-03 |
| N0-vs-N2 |
9.488800E-01 |
| N1-vs-N2 |
2.487600E-01 |
|
|
